INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

Go back to INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
(NASDAQ: INMB) Delayed: 1.46 +0.03 (2.10%)
Previous Close $1.43    52 Week High
Open $1.39    52 Week Low
Day High $1.50    P/E N/A 
Day Low $1.39    EPS
Volume 290,349